This post is part of a series where I elaborate on questions I was asked after my keynote in the 13th International Shared Decision Making (ISDM) Conference, hosted at Dartmouth College, USA, July 7, 2026 to July 10, 2026. From the conference website: “With the 2026 theme, ‘A Wider Lens,’ this year’s conference will bring together clinicians, researchers, patients, and policy leaders to expand our understanding of shared decision-making across specialties, care settings, and systems.” You can find links to my recorded keynote and to the other posts in the series at the end of this post.

The question I was asked:

“I think at the root of your message there is a very powerful insight, patients also develop knowledge that should be considered. What is striking to me then, who takes responsability if the new way of taking the pills makes any harm to the other patients?”

Excellent question, and important to be precise about: nothing I say in my presentation removes clinical responsibility. My neurologist didn’t just copy what I did — he evaluated it against his own knowledge and judgment, and made a professional decision to prescribe that way. My observation was an input into his reasoning, not a substitute for it. Patient phronesis is raw material for clinical decisions; the clinician stays accountable for what they do with it, same as with any other information they weigh.

It’s also worth naming the asymmetry underneath the question: most clinicians don’t actually know whether or how their patients are taking their medications as prescribed in the first place. As soon as we leave our doctor’s office, we go back to our real lives, where we forget to take our pills on time because we were enjoying a deep conversation with someone we love. Or we experience really bad side effects on a Saturday and the doctor isn’t available again until Monday morning. Or we don’t take our pills because we can’t afford them. (In this context, I strongly recommend checking out the work by Victor Montori and others on “the burden of treatment”) This happens all the time, without being reported — so in a strange way, a patient who observes, experiments deliberately, and then reports back, like I did, is offering far more visibility into real-world medication use than the silent default the system usually gets.

Here are links to the other posts in this series:

• My recorded keynote for ISDM2026
• “How can we trust patients’ knowledge when there are anti-vaxxers and science deniers?”
• “What’s your opinion on healthcare delivered patient education?”
• “Who takes responsibility if the new way of taking pills harms other patients?”
• “Is epistemic injustice equally distributed, or stratified?”
• “How could we elicit Chronic Knowledge during a consultation? What question would you want to be asked?”
• “Is shared decision making ready to see the blue dots?”